Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Biodegradable composite porous poly(dl-lactide-co-glycolide) scaffold supports mesenchymal stem cell differentiation and calcium phosphate deposition.

Casagrande S, Tiribuzi R, Cassetti E, Selmin F, Gervasi GL, Barberini L, Freddolini M, Ricci M, Schoubben A, Cerulli GG, Blasi P.

Artif Cells Nanomed Biotechnol. 2017 Dec 21:1-11. doi: 10.1080/21691401.2017.1417866. [Epub ahead of print]

PMID:
29265950
2.

Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.

Maleki A, Kettiger H, Schoubben A, Rosenholm JM, Ambrogi V, Hamidi M.

J Control Release. 2017 Sep 28;262:329-347. doi: 10.1016/j.jconrel.2017.07.047. Epub 2017 Aug 2. Review.

PMID:
28778479
3.

The long and winding road to inhaled TB therapy: not only the bug's fault.

Giovagnoli S, Schoubben A, Ricci M.

Drug Dev Ind Pharm. 2017 Mar;43(3):347-363. doi: 10.1080/03639045.2016.1272119. Epub 2017 Jan 5. Review.

PMID:
27977937
4.

Quantitative assay of capreomycin oleate levels in a drug formulation for inhalation with a fully validated HPLC method.

Ianni F, Schoubben A, Montesano D, Wauthoz N, Cossignani L, Sardella R, Natalini B.

J Pharm Biomed Anal. 2016 Feb 20;120:413-8. doi: 10.1016/j.jpba.2015.11.040. Epub 2015 Nov 28.

PMID:
26680112
5.

Alginates in Pharmaceutics and Biomedicine: Is the Future so Bright?

Giovagnoli S, Luca G, Blasi P, Mancuso F, Schoubben A, Arato I, Calvitti M, Falabella G, Basta G, Bodo M, Calafiore R, Ricci M.

Curr Pharm Des. 2015;21(33):4917-35. Review.

PMID:
26290204
6.

Powder, capsule and device: An imperative ménage à trois for respirable dry powders.

Schoubben A, Blasi P, Giontella A, Giovagnoli S, Ricci M.

Int J Pharm. 2015 Oct 15;494(1):40-8. doi: 10.1016/j.ijpharm.2015.08.012. Epub 2015 Aug 5.

PMID:
26255220
7.

Effect of fermentation and drying on cocoa polyphenols.

Albertini B, Schoubben A, Guarnaccia D, Pinelli F, Della Vecchia M, Ricci M, Di Renzo GC, Blasi P.

J Agric Food Chem. 2015 Nov 18;63(45):9948-53. doi: 10.1021/acs.jafc.5b01062. Epub 2015 Jul 6.

PMID:
26086521
8.

Dynamic behavior of a spring-powered micronozzle needle-free injector.

Schoubben A, Cavicchi A, Barberini L, Faraon A, Berti M, Ricci M, Blasi P, Postrioti L.

Int J Pharm. 2015 Aug 1;491(1-2):91-8. doi: 10.1016/j.ijpharm.2015.05.067. Epub 2015 May 29.

PMID:
26027490
10.

Capreomycin inhalable powders prepared with an innovative spray-drying technique.

Schoubben A, Giovagnoli S, Tiralti MC, Blasi P, Ricci M.

Int J Pharm. 2014 Jul 20;469(1):132-9. doi: 10.1016/j.ijpharm.2014.04.042. Epub 2014 Apr 18.

PMID:
24747443
11.

Synthesis, characterization and in vitro extracellular and intracellular activity against Mycobacterium tuberculosis infection of new second-line antitubercular drug-palladium complexes.

Giovagnoli S, Marenzoni ML, Nocchetti M, Santi C, Blasi P, Schoubben A, Ricci M.

J Pharm Pharmacol. 2014 Jan;66(1):106-21. doi: 10.1111/jphp.12162. Epub 2013 Oct 31.

PMID:
24341950
12.

Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity.

Blasi P, Schoubben A, Traina G, Manfroni G, Barberini L, Alberti PF, Cirotto C, Ricci M.

Int J Pharm. 2013 Sep 15;454(1):316-23. doi: 10.1016/j.ijpharm.2013.06.037. Epub 2013 Jul 4.

PMID:
23832009
13.

Nanoparticles in biomedicine: new insights from plant viruses.

Lico C, Schoubben A, Baschieri S, Blasi P, Santi L.

Curr Med Chem. 2013;20(28):3471-87. Review.

PMID:
23745557
14.

Lipid nanoparticles for brain targeting II. Technological characterization.

Blasi P, Schoubben A, Romano GV, Giovagnoli S, Di Michele A, Ricci M.

Colloids Surf B Biointerfaces. 2013 Oct 1;110:130-7. doi: 10.1016/j.colsurfb.2013.04.021. Epub 2013 May 7.

PMID:
23711783
15.

Capreomycin supergenerics for pulmonary tuberculosis treatment: preparation, in vitro, and in vivo characterization.

Schoubben A, Blasi P, Marenzoni ML, Barberini L, Giovagnoli S, Cirotto C, Ricci M.

Eur J Pharm Biopharm. 2013 Apr;83(3):388-95. doi: 10.1016/j.ejpb.2012.11.005. Epub 2012 Dec 5.

PMID:
23220041
16.

Developing and advancing dry powder inhalation towards enhanced therapeutics.

Stegemann S, Kopp S, Borchard G, Shah VP, Senel S, Dubey R, Urbanetz N, Cittero M, Schoubben A, Hippchen C, Cade D, Fuglsang A, Morais J, Borgström L, Farshi F, Seyfang KH, Hermann R, van de Putte A, Klebovich I, Hincal A.

Eur J Pharm Sci. 2013 Jan 23;48(1-2):181-94. doi: 10.1016/j.ejps.2012.10.021. Epub 2012 Nov 7. Review.

PMID:
23142635
17.

Conformal polymer coatings for pancreatic islets transplantation.

Blasi P, Luca G, Mancuso F, Schoubben A, Calvitti M, Giovagnoli S, Basta G, Becchetti E, Ricci M, Calafiore R.

Int J Pharm. 2013 Jan 20;440(2):141-7. doi: 10.1016/j.ijpharm.2012.10.010. Epub 2012 Oct 16.

PMID:
23078858
18.

Development of a spray-drying method for the formulation of respirable microparticles containing ofloxacin-palladium complex.

Palazzo F, Giovagnoli S, Schoubben A, Blasi P, Rossi C, Ricci M.

Int J Pharm. 2013 Jan 20;440(2):273-82. doi: 10.1016/j.ijpharm.2012.05.045. Epub 2012 May 29.

PMID:
22659124
19.

Effect of agitation regimen on the in vitro release of leuprolide from poly(lactic-co-glycolic) acid microparticles.

Schoubben A, Blasi P, Deluca PP.

J Pharm Sci. 2012 Mar;101(3):1212-20. doi: 10.1002/jps.23029. Epub 2011 Dec 21.

PMID:
22189694
20.

Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies.

Puglia C, Bonina F, Rizza L, Blasi P, Schoubben A, Perrotta R, Tarico MS, Damiani E.

J Pharm Sci. 2012 Jan;101(1):301-11. doi: 10.1002/jps.22741. Epub 2011 Sep 8.

PMID:
21905033

Supplemental Content

Loading ...
Support Center